p53 polymorphisms: cancer implications - PubMed (original) (raw)
Review
doi: 10.1038/nrc2584.
Affiliations
- PMID: 19165225
- DOI: 10.1038/nrc2584
Review
p53 polymorphisms: cancer implications
Catherine Whibley et al. Nat Rev Cancer. 2009 Feb.
Abstract
The normal functioning of p53 is a potent barrier to cancer. Tumour-associated mutations in TP53, typically single nucleotide substitutions in the coding sequence, are a hallmark of most human cancers and cause dramatic defects in p53 function. By contrast, only a small fraction, if any, of the >200 naturally occurring sequence variations (single nucleotide polymorphisms, SNPs) of TP53 in human populations are expected to cause measurable perturbation of p53 function. Polymorphisms in the TP53 locus that might have cancer-related phenotypical manifestations are the subject of this Review. Polymorphic variants of other genes in the p53 pathway, such as MDM2, which might have biological consequences either individually or in combination with p53 variants are also discussed.
Similar articles
- Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment.
Hrstka R, Coates PJ, Vojtesek B. Hrstka R, et al. J Cell Mol Med. 2009 Mar;13(3):440-53. doi: 10.1111/j.1582-4934.2008.00634.x. J Cell Mol Med. 2009. PMID: 19379143 Free PMC article. Review. - Common genetic variants in the TP53 pathway and their impact on cancer.
Barnoud T, Parris JLD, Murphy ME. Barnoud T, et al. J Mol Cell Biol. 2019 Jul 19;11(7):578-585. doi: 10.1093/jmcb/mjz052. J Mol Cell Biol. 2019. PMID: 31152665 Free PMC article. Review. - p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers.
Macedo GS, Vieira IA, Vianna FSL, Alemar B, Giacomazzi J, Brandalize APC, Caleffi M, Volc SM, de Campos Reis Galvão H, Palmero EI, Achatz MI, Ashton-Prolla P. Macedo GS, et al. Fam Cancer. 2018 Apr;17(2):269-274. doi: 10.1007/s10689-017-0028-4. Fam Cancer. 2018. PMID: 28756477 - A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.
Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, Onel K, Yip L, Hwang SJ, Strong LC, Lozano G, Levine AJ. Bond GL, et al. Cell. 2004 Nov 24;119(5):591-602. doi: 10.1016/j.cell.2004.11.022. Cell. 2004. PMID: 15550242 - The Enigma of p53.
Lozano G. Lozano G. Cold Spring Harb Symp Quant Biol. 2016;81:37-40. doi: 10.1101/sqb.2016.81.031062. Epub 2016 Dec 8. Cold Spring Harb Symp Quant Biol. 2016. PMID: 27932563 Review.
Cited by
- The role of p53 in male infertility.
Li J, Huang X, Luo L, Sun J, Guo Q, Yang X, Zhang C, Ni B. Li J, et al. Front Endocrinol (Lausanne). 2024 Oct 14;15:1457985. doi: 10.3389/fendo.2024.1457985. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39469578 Free PMC article. Review. - Germline variant affecting p53β isoforms predisposes to familial cancer.
Schubert SA, Ruano D, Joruiz SM, Stroosma J, Glavak N, Montali A, Pinto LM, Rodríguez-Girondo M, Barge-Schaapveld DQCM, Nielsen M, van Nesselrooij BPM, Mensenkamp AR, van Leerdam ME, Sharp TH, Morreau H, Bourdon JC, de Miranda NFCC, van Wezel T. Schubert SA, et al. Nat Commun. 2024 Sep 18;15(1):8208. doi: 10.1038/s41467-024-52551-8. Nat Commun. 2024. PMID: 39294166 Free PMC article. - p53 Genetics and Biology in Lung Carcinomas: Insights, Implications and Clinical Applications.
Benitez DA, Cumplido-Laso G, Olivera-Gómez M, Del Valle-Del Pino N, Díaz-Pizarro A, Mulero-Navarro S, Román-García A, Carvajal-Gonzalez JM. Benitez DA, et al. Biomedicines. 2024 Jun 29;12(7):1453. doi: 10.3390/biomedicines12071453. Biomedicines. 2024. PMID: 39062026 Free PMC article. Review. - Interactive Association of XRCC1, XRCC2, XRCC3, and TP53 Gene Polymorphisms With Gastrointestinal Cancer Risk: Insights From a Hospital-Based Case-Control Study.
Datkhile KD, Gudur R, Patil MN, Gudur A. Datkhile KD, et al. Cureus. 2024 Jun 7;16(6):e61921. doi: 10.7759/cureus.61921. eCollection 2024 Jun. Cureus. 2024. PMID: 38983993 Free PMC article. - Anticancer Mechanism of Astragalus Polysaccharide and Its Application in Cancer Immunotherapy.
He Z, Liu X, Qin S, Yang Q, Na J, Xue Z, Zhong L. He Z, et al. Pharmaceuticals (Basel). 2024 May 15;17(5):636. doi: 10.3390/ph17050636. Pharmaceuticals (Basel). 2024. PMID: 38794206 Free PMC article. Review.
References
- J Natl Cancer Inst. 2006 Jul 5;98(13):911-9 - PubMed
- Cancer Res. 2007 Mar 15;67(6):2757-65 - PubMed
- Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15335-40 - PubMed
- Breast Cancer Res Treat. 2006 Jun;97(3):255-62 - PubMed
- Cancer Lett. 2002 Sep 26;183(2):123-30 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous